is a topic covered in the Johns Hopkins ABX Guide
To view the entire topic, please sign in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
- Treatment of adult patients with chronic HCV infection without cirrhosis or compensated cirrhosis (Child-Pugh A) who have:
- Genotype 1, 2, 3, 4, 5 or 6 infection who have previously been treated with an HCV regimen containing an NS5A inhibitor
- Genotype 1a or 3 infection and have been previously treated with sofosbuvir without an NS5A inhibitor
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: June 4, 2018
Dzintars, Kathryn. "Vosevi." Johns Hopkins ABX Guide, The Johns Hopkins University, 2018. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540689/all/Vosevi.
Dzintars K. Vosevi. Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540689/all/Vosevi. Accessed April 23, 2019.
Dzintars, K. (2018). Vosevi. In Johns Hopkins ABX Guide. Available from https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540689/all/Vosevi
Dzintars K. Vosevi [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. [cited 2019 April 23]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540689/all/Vosevi.
TY - ELEC
T1 - Vosevi
ID - 540689
A1 - Dzintars,Kathryn,Pharm.D., BCPS
Y1 - 2018/06/04/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540689/all/Vosevi
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine